Published in Thrombosis on November 24, 2011
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med (2013) 1.03
Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs (2015) 0.77
Fruitflow(®): the first European Food Safety Authority-approved natural cardio-protective functional ingredient. Eur J Nutr (2016) 0.75
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet (2001) 6.38
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med (1983) 6.00
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem (1991) 5.62
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet (1997) 5.27
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.11
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ (2000) 3.02
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med (1985) 2.99
The mechanism of action of aspirin. Thromb Res (2003) 2.72
Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest (1990) 2.66
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39
Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.81
The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Can J Cardiol (2000) 1.77
Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke (2010) 1.62
Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol (2011) 1.59
Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation (1988) 1.57
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Should aspirin be used with angiotensin-converting enzyme inhibitors in patients with chronic heart failure? Congest Heart Fail (2003) 1.40
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1997) 1.28
Aspirin improves endothelial dysfunction in atherosclerosis. Circulation (1998) 1.27
Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation (1991) 1.23
History of aspirin and its mechanism of action. Stroke (1990) 1.04
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg (2005) 0.96
Aspirin protects low density lipoprotein from oxidative modification. Heart (1997) 0.88
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation (1987) 0.87
The physicians' health study: aspirin for the primary prevention of myocardial infarction. N Engl J Med (1988) 0.86
Aspirin resistance: an update. Curr Atheroscler Rep (2009) 0.85
Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty. Am J Cardiol (1990) 0.84
Antithrombotic treatment in atrial fibrillation. Heart (2006) 0.84
Aspirin resistance: biological and clinical implications. J Cardiovasc Pharmacol Ther (2008) 0.83
Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact. Curr Pharm Des (2009) 0.83
Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. Eur J Heart Fail (2008) 0.81
Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol (1991) 0.80
Hypertension Optimal Treatment (HOT) trial. Lancet (1998) 0.79
Aspirin resistance: disparities and clinical implications. Pharmacotherapy (2008) 0.79
Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention. Heart Vessels (2008) 0.78
Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure. Int J Cardiol (2003) 0.77
European atrial fibrillation trial. Acta Neurol Belg (1988) 0.77
Aspirin resistance in atherosclerosis. Curr Atheroscler Rep (2008) 0.76
Impact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention. Int Heart J (2006) 0.76
Interaction of angiotensin-converting enzyme inhibition and aspirin in congestive heart failure: long controversy finally resolved? Chest (2003) 0.76
Update on myocardial bridging. Circulation (2002) 3.29
Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept (2004) 2.56
Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg (2005) 2.35
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract (2009) 1.90
Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol (2005) 1.76
Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. EMBO Rep (2008) 1.40
Biodegradable polymer versus permanent polymer sirolimus-eluting stents in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol (2012) 1.39
Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol (2009) 1.34
A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis (2010) 1.25
Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med (2010) 1.23
Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice. J Cardiovasc Pharmacol (2012) 1.22
Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res (2013) 1.15
Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem (2006) 1.13
CXCR6 deficiency ameliorated myocardial ischemia/reperfusion injury by inhibiting infiltration of monocytes and IFN-γ-dependent autophagy. Int J Cardiol (2012) 1.08
Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. J Ultrasound Med (2010) 1.08
Telocytes in mice bone marrow: electron microscope evidence. J Cell Mol Med (2014) 1.07
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes (2014) 1.06
microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos. J Lipid Res (2012) 1.05
Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail (2009) 1.03
Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res (2010) 1.03
Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet. Curr Pharm Des (2013) 1.01
Scanning electron microscope evidence of telocytes in vasculature. J Cell Mol Med (2014) 1.00
The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials (2009) 0.99
Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur J Hum Genet (2005) 0.99
Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care (2012) 0.98
Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension (2011) 0.98
Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials (2009) 0.98
Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res Ther (2013) 0.98
Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med (2012) 0.98
Meta-analysis of early versus deferred revascularization for non-ST-segment elevation acute coronary syndrome. Am J Cardiol (2011) 0.98
Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res (2010) 0.97
High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci (2012) 0.97
Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. J Am Coll Cardiol (2012) 0.96
Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler Thromb Vasc Biol (2012) 0.96
MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. Curr Pharm Des (2013) 0.96
High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy. Biochem Biophys Res Commun (2010) 0.95
Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant (2005) 0.95
Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J (2007) 0.95
Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies. Int J Cardiol (2011) 0.94
Comparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine model. J Biomed Biotechnol (2012) 0.94
MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J (2012) 0.93
Myocardial bridging: a congenital variant as an anatomic risk factor for myocardial infarction? Circulation (2009) 0.92
Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. Clin Cardiol (2010) 0.91
Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv (2014) 0.90
Heat shock transcription factor-1 inhibits H2O2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Mol Cell Biochem (2010) 0.90
Danhong inhibits oxidized low-density lipoprotein-induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor γ-mediated pathway. J Pharmacol Sci (2012) 0.90
The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. Virology (2011) 0.90
Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex. J Cell Mol Med (2012) 0.90
Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol (2011) 0.89
Association of Stat3 with HSF1 plays a critical role in G-CSF-induced cardio-protection against ischemia/reperfusion injury. J Mol Cell Cardiol (2012) 0.89
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol (2011) 0.89
Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study. Crit Care (2011) 0.88
Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochem Biophys Res Commun (2010) 0.88
Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics (2012) 0.88
Extraction, chemical analysis of Angelica sinensis polysaccharides and antioxidant activity of the polysaccharides in ischemia-reperfusion rats. Int J Biol Macromol (2010) 0.88
Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol (2010) 0.88
A role of myocardial stiffness in cell-based cardiac repair: a hypothesis. J Cell Mol Med (2009) 0.88
Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther (2014) 0.87
Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction. Mol Med (2012) 0.87
Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells. J Cell Mol Med (2011) 0.87
Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPARγ. Br J Pharmacol (2011) 0.87
Transfer of bone-marrow-derived mesenchymal stem cells influences vascular remodeling and calcification after balloon injury in hyperlipidemic rats. J Biomed Biotechnol (2012) 0.87
High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Mol Cell Biochem (2012) 0.86
Isolation, culture, and identification of amniotic fluid-derived mesenchymal stem cells. Cell Biochem Biophys (2013) 0.86
Relationships between paced QRS duration and left cardiac structures and function. Acta Cardiol (2009) 0.86
The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials (2013) 0.86
Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model. Cardiovasc Res (2006) 0.86
Tongxinluo inhibits oxidized low-density lipoprotein-induced maturation of human dendritic cells via activating peroxisome proliferator-activated receptor gamma pathway. J Cardiovasc Pharmacol (2010) 0.86
Evaluation of MTT assay for measurement of emodin-induced cytotoxicity. Assay Drug Dev Technol (2006) 0.85
A novel method to delivery stem cells to the injured heart: spatially focused magnetic targeting strategy. J Cell Mol Med (2012) 0.85
Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53. J Cardiovasc Pharmacol (2007) 0.85
The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem (2003) 0.85
Peripheral-blood dendritic cells in men with coronary heart disease. Am J Cardiol (2007) 0.85
Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model. Biomed Res Int (2013) 0.85
Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells (2007) 0.84
Multiple ST-segment elevations in anterior and inferior leads: an unusual electrocardiographic manifestation in acute pulmonary embolism. Int J Cardiol (2012) 0.84
Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study. Lipids Health Dis (2012) 0.84
Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway. Biomed Pharmacother (2009) 0.84
Role of the JAK/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-κB expression. Mol Med Rep (2012) 0.84
Regulation of p53 by jagged1 contributes to angiotensin II-induced impairment of myocardial angiogenesis. PLoS One (2013) 0.84
The role of SDF-1α/Rac pathway in the regulation of endothelial progenitor cell polarity; homing and expression of Rac1, Rac2 during endothelial repair. Mol Cell Biochem (2011) 0.84
Streptococcus acidominimus causing invasive disease in humans: a case series. J Med Case Rep (2014) 0.84
AngiotensinII preconditioning promotes angiogenesis in vitro via ERKs phosphorylation. J Biomed Biotechnol (2012) 0.84
A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway. J Cell Mol Med (2014) 0.84
Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis. Ann Med (2010) 0.83
Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart. FEMS Immunol Med Microbiol (2011) 0.83
Ligating LAD with its whole length rather than diagonal branches as coordinates is more advisable in establishing stable myocardial infarction model of swine. Exp Anim (2010) 0.83
Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization. Arch Med Sci (2012) 0.83
High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells. Cardiovasc Diabetol (2013) 0.83
Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis. Eur J Intern Med (2011) 0.83
Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus. Am J Cardiol (2009) 0.83
Prioritizing Proteomics Assay Development for Clinical Translation. J Am Coll Cardiol (2015) 0.82
Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report. Cardiovasc Diabetol (2011) 0.82
Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells. J Cardiovasc Pharmacol (2004) 0.82
A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis? J Cell Mol Med (2014) 0.82
Automatic segmentation of calcifications in intravascular ultrasound images using snakes and the contourlet transform. Ultrasound Med Biol (2010) 0.82
Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis. Microvasc Res (2007) 0.82
Comparison of Magnetic Intensities for Mesenchymal Stem Cell Targeting Therapy on Ischemic Myocardial Repair: High Magnetic Intensity Improves Cell Retention but Has no Additional Functional Benefit. Cell Transplant (2014) 0.82
Role of Jagged1 in arterial lesions after vascular injury. Arterioscler Thromb Vasc Biol (2011) 0.82
Heat shock transcription factor 1 inhibits H₂O₂-induced cardiomyocyte death through suppression of high-mobility group box 1. Mol Cell Biochem (2012) 0.82